AU2014253785B2 - Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones - Google Patents

Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones Download PDF

Info

Publication number
AU2014253785B2
AU2014253785B2 AU2014253785A AU2014253785A AU2014253785B2 AU 2014253785 B2 AU2014253785 B2 AU 2014253785B2 AU 2014253785 A AU2014253785 A AU 2014253785A AU 2014253785 A AU2014253785 A AU 2014253785A AU 2014253785 B2 AU2014253785 B2 AU 2014253785B2
Authority
AU
Australia
Prior art keywords
ala
leu
lys
val
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014253785A
Other languages
English (en)
Other versions
AU2014253785A1 (en
Inventor
Dan Groff
Patrick RIVERS
Christopher D. Thanos
Alice Yam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sutro Biopharma Inc
Original Assignee
Sutro Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutro Biopharma Inc filed Critical Sutro Biopharma Inc
Publication of AU2014253785A1 publication Critical patent/AU2014253785A1/en
Application granted granted Critical
Publication of AU2014253785B2 publication Critical patent/AU2014253785B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2014253785A 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones Active AU2014253785B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361813914P 2013-04-19 2013-04-19
US61/813,914 2013-04-19
US201461937069P 2014-02-07 2014-02-07
US61/937,069 2014-02-07
PCT/US2014/034643 WO2014172631A2 (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression

Publications (2)

Publication Number Publication Date
AU2014253785A1 AU2014253785A1 (en) 2015-11-05
AU2014253785B2 true AU2014253785B2 (en) 2018-07-19

Family

ID=50733442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014253785A Active AU2014253785B2 (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Country Status (13)

Country Link
US (3) US10190145B2 (enExample)
EP (1) EP2986731B1 (enExample)
JP (2) JP6463732B2 (enExample)
KR (1) KR102289258B1 (enExample)
CN (1) CN105283556B (enExample)
AU (1) AU2014253785B2 (enExample)
CA (1) CA2909516C (enExample)
DK (1) DK2986731T3 (enExample)
ES (1) ES2922358T3 (enExample)
HU (1) HUE059565T2 (enExample)
IL (1) IL242148B (enExample)
SG (2) SG10202108497TA (enExample)
WO (1) WO2014172631A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE059565T2 (hu) * 2013-04-19 2022-11-28 Sutro Biopharma Inc Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségével
US10316322B2 (en) * 2014-07-02 2019-06-11 Sutro Biopharma, Inc. High growth capacity auxotrophic Escherichia coli and methods of use
WO2016073794A1 (en) 2014-11-05 2016-05-12 Genentech, Inc. Methods of producing two chain proteins in bacteria
WO2016073791A1 (en) 2014-11-05 2016-05-12 Genentech, Inc. Methods of producing two chain proteins in bacteria
WO2016100889A1 (en) * 2014-12-19 2016-06-23 Sutro Biopharma, Inc. Codon optimization for titer and fidelity improvement
KR102489471B1 (ko) 2014-12-30 2023-01-18 셀진 코포레이션 항-cd47 항체 및 그 용도
SI3265557T1 (sl) * 2015-03-06 2020-02-28 F. Hoffmann-La Roche Ag Ultraprečiščena DsbA in DsbC ter postopki njune izdelave in uporabe
US20170029798A1 (en) * 2015-07-27 2017-02-02 Cellivery Therapeutics, Inc. Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
MX2018002068A (es) * 2015-08-20 2018-06-06 Genentech Inc Purificacion de fkpa y usos de la misma para producir polipeptidos recombinantes.
CN105198983B (zh) * 2015-09-11 2018-11-06 中国石油大学(华东) 一种利于七次跨膜蛋白ccr5功能性表达的方法
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
CN106399352B (zh) * 2016-11-09 2020-04-17 华东理工大学 调节目标蛋白表达的折叠因子及其应用
DK3562940T3 (da) * 2016-12-30 2022-07-11 Natures Toolbox Inc Cellefrit ekspressionssystem med hidtil ukendt, uorganisk polyphosphatbaseret energiregeneration
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
KR20240110660A (ko) 2016-12-30 2024-07-15 박사이트, 인코포레이티드 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체
US12227778B2 (en) 2016-12-30 2025-02-18 Nature's Toolbox, Inc. Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
AR112756A1 (es) 2017-07-11 2019-12-11 Synthorx Inc Incorporación de nucleótidos no naturales, y su método
MX2020001336A (es) 2017-08-03 2020-08-20 Synthorx Inc Conjugados de citoquina para el tratamiento de enfermedades autoinmunes.
US20200181670A1 (en) * 2017-08-11 2020-06-11 Synvitrobio, Inc. Improved In Vitro Transcription/Translation (TXTL) System and Use Thereof
WO2019127469A1 (zh) * 2017-12-29 2019-07-04 康码(上海)生物科技有限公司 一种高效的能源再生体系(bes)、试剂盒及其制备方法
TWI834636B (zh) 2018-02-26 2024-03-11 美商欣爍克斯公司 Il-15結合物及其用途
WO2020014543A2 (en) * 2018-07-11 2020-01-16 Actym Therapeutics, Inc. Engineered immunostimulatory bacterial strains and uses thereof
WO2020096959A1 (en) * 2018-11-05 2020-05-14 Genentech, Inc. Methods of producing two chain proteins in prokaryotic host cells
JP7426389B2 (ja) * 2018-11-08 2024-02-01 ストロ バイオファーマ, インコーポレイテッド 酸化的細胞質を有する大腸菌株
JP7636323B2 (ja) 2018-11-08 2025-02-26 シンソークス, インコーポレイテッド インターロイキン10コンジュゲートおよびその使用
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
JP7702872B2 (ja) 2019-02-06 2025-07-04 シンソークス, インコーポレイテッド Il-2コンジュゲートおよびその使用方法
US12024709B2 (en) 2019-02-27 2024-07-02 Actym Therapeutics, Inc. Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
CA3150163A1 (en) 2019-08-15 2021-02-18 Synthorx, Inc. Immuno oncology combination therapies with il-2 conjugates
TW202124385A (zh) 2019-09-10 2021-07-01 美商欣爍克斯公司 治療自體免疫疾病之il-2接合物及使用方法
MX2022005251A (es) 2019-11-04 2022-06-08 Synthorx Inc Conjugados de interleuquina 10 y sus usos.
EP4056584A4 (en) * 2019-11-08 2024-06-05 Korea Institute of Ocean Science & Technology NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF
EP4114931A4 (en) * 2020-03-05 2024-05-01 Curie Co. Inc. METHODS FOR CELL PROTEIN EXPRESSION OF MATURE POLYPEPTIDES DERIVED FROM ZYMOGENS AND PROPROTEINS
CA3175683A1 (en) * 2020-04-29 2021-11-04 Xueyang FENG Compositions and methods for enhancing recombinant biosynthesis of cannabinoids
BR112022026236A2 (pt) 2020-06-25 2023-01-17 Synthorx Inc Terapia de combinação de imuno-oncologia com conjugados de il-2 e anticorpos anti-egfr
KR20220000028U (ko) 2020-06-29 2022-01-05 채인자 농작물용 농약 간편 분무장치
US20220089690A1 (en) * 2020-09-14 2022-03-24 Sutro Biopharma, Inc. Method for large scale production of antibodies using a cell-free protein synthesis system
IL301612A (en) 2020-10-09 2023-05-01 Synthorx Inc Immuno oncology therapies with il-2 conjugates
BR112023006364A2 (pt) 2020-10-09 2023-05-09 Synthorx Inc Terapia de combinação de imuno-oncologia com conjugados de il-2 e pembrolizumabe
WO2022174101A1 (en) 2021-02-12 2022-08-18 Synthorx, Inc. Skin cancer combination therapy with il-2 conjugates and cemiplimab
EP4291243A1 (en) 2021-02-12 2023-12-20 Synthorx, Inc. Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
EP4346903A1 (en) 2021-06-03 2024-04-10 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
EP4452327A1 (en) 2021-12-20 2024-10-30 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab
CA3255881A1 (en) * 2022-06-17 2023-12-21 Insitro Inc In situ sequencing of RNA transcripts with non-uniform 5' ends
CN115028691B (zh) * 2022-06-29 2024-09-10 青岛硕景生物科技有限公司 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用
WO2024136899A1 (en) 2022-12-21 2024-06-27 Synthorx, Inc. Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies
WO2024196937A1 (en) 2023-03-20 2024-09-26 Synthorx, Inc. Cancer therapy with il-2 peg conjugates
CN116925196B (zh) * 2023-06-08 2025-04-18 齐鲁工业大学(山东省科学院) 小分子热休克蛋白rsp_1572在提高宿主菌环境耐受性中的应用
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
CN118048325B (zh) * 2024-04-16 2024-07-16 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003025116A2 (de) * 2001-09-17 2003-03-27 Roche Diagnostics Gmbh Verfahren zur erhöhung der löslichkeit, der expressionsrate und der aktivität von proteinen während der rekombinanten herstellung
WO2008066583A2 (en) * 2006-06-29 2008-06-05 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
US7871794B2 (en) * 2007-01-18 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004081033A2 (en) * 2003-03-11 2004-09-23 National Institutes Of Health Synthesis of proteins by cell-free protein expression
JP2005253432A (ja) 2004-03-15 2005-09-22 Sekisui Chem Co Ltd タンパク質の生産方法、並びにそれに使用するための組成物、試薬及びキット
JP4561243B2 (ja) 2004-08-27 2010-10-13 株式会社豊田中央研究所 無細胞タンパク質合成系のための媒体
CN102348807B (zh) 2009-01-12 2015-04-15 苏特罗生物制药公司 利用体外蛋白合成体系将非天然氨基酸引入蛋白的单装载体系
CN102732548A (zh) 2012-05-16 2012-10-17 中国农业大学 一种表达蛇毒激肽原酶的高效麦胚无细胞蛋白合成系统的建立及应用
JP6421122B2 (ja) * 2012-10-12 2018-11-07 ストロ バイオファーマ, インコーポレイテッド 改善された発現のための、細菌抽出物中の選択タンパク質のタンパク質分解不活性化
HUE059565T2 (hu) 2013-04-19 2022-11-28 Sutro Biopharma Inc Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségével

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003025116A2 (de) * 2001-09-17 2003-03-27 Roche Diagnostics Gmbh Verfahren zur erhöhung der löslichkeit, der expressionsrate und der aktivität von proteinen während der rekombinanten herstellung
WO2008066583A2 (en) * 2006-06-29 2008-06-05 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
US7871794B2 (en) * 2007-01-18 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KANG, S.-H. ET AL., "Cell-Free Production of Aggregation-Prone Proteins in Soluble and Active Forms", BIOTECHNOLOGY PROGRESS, (2005), vol. 21, no. 4, pages 1412 - 1419 *
OH, I.-S. ET AL., "Cell-free production of functional antibody fragments", BIOPROCESS AND BIOSYSTEMS ENGINEERING, (2009), vol. 33, no. 1 *
OH, I.-S. ET AL., BIOTECHNOLOGY PROGRESS, (2006), vol. 22, no. 4, pages 1225 -1228 *
XU, Y. ET AL., "Effect of folding factors in rescuing unstable heterologous lipase B to enhance its overexpression in the periplasm of Escherichia coli", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, (2008), vol. 79, no. 6, pages 1035 -1044 *

Also Published As

Publication number Publication date
JP6463732B2 (ja) 2019-02-06
IL242148B (en) 2019-03-31
HK1220993A1 (en) 2017-05-19
WO2014172631A4 (en) 2015-02-19
JP2016518833A (ja) 2016-06-30
KR20160002913A (ko) 2016-01-08
US20140315245A1 (en) 2014-10-23
EP2986731B1 (en) 2022-05-18
CA2909516A1 (en) 2014-10-23
SG10202108497TA (en) 2021-09-29
EP2986731A2 (en) 2016-02-24
DK2986731T3 (da) 2022-08-01
US20190161781A1 (en) 2019-05-30
KR102289258B1 (ko) 2021-08-11
CA2909516C (en) 2023-03-07
US10774354B2 (en) 2020-09-15
US10190145B2 (en) 2019-01-29
JP2018157837A (ja) 2018-10-11
WO2014172631A2 (en) 2014-10-23
CN105283556B (zh) 2020-07-14
SG11201508642WA (en) 2015-11-27
WO2014172631A3 (en) 2014-12-18
US20210054429A1 (en) 2021-02-25
ES2922358T3 (es) 2022-09-13
CN105283556A (zh) 2016-01-27
AU2014253785A1 (en) 2015-11-05
HUE059565T2 (hu) 2022-11-28

Similar Documents

Publication Publication Date Title
US10774354B2 (en) Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression
US10487133B2 (en) Codon optimization for titer and fidelity improvement
US7871794B2 (en) Enhanced cell-free synthesis of active proteins containing disulfide bonds
CN101479379A (zh) 含有非天然氨基酸的蛋白质的无细胞合成
US20200332280A1 (en) Use of lambda-gam protein in ribosomal display technology
US20220089690A1 (en) Method for large scale production of antibodies using a cell-free protein synthesis system
HK1220993B (en) Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
WO2005105994A1 (ja) ジスルフィド架橋形成型インビトロタンパク質合成方法
TWI899326B (zh) 使用無細胞蛋白質合成系統來大規模生產抗體之方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)